Well from that aspect, yes, Cytodyn would be their only savior, but my point was focused on Gilead's product line, which Leronlimab is far superior to any drug they currently have on the market in both safety / efficacy. Lastly, why would we want to integrate a drug that has known side effects on the exact organs we are trying to help? Gilead already has large lawsuits against them for their drugs and their side effects, one example is NASH.